Filed: 8/14/2025ACC: 0001420506-25-002146
📋 What this filing means
SILVERARC CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 65 equity positions with a total reported market value of $542.29M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
65
Positions
$542.29M
Total AUM (reported)
45.40M
Total Shares
Allocation by class
COM$364.04M67.1%
CALL$49.74M9.2%
SPONSORED ADS$38.47M7.1%
COM PAR $.01$25.07M4.6%
COM NEW$19.64M3.6%
SPONSORED ADR$14.94M2.8%
CL A ORD SHS$6.51M1.2%
Portfolio Concentration
Top 3$111.00M20.5%
4–10$159.42M29.4%
11–25$178.93M33.0%
Rest$92.94M17.1%
Top 3 weight
20.5%
Top 10 weight
49.9%
Voting Authority Distribution
Total shares with voting rights: 45.40M
Sole
Full voting authority
45.40M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole65
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings65
Rows:
MERUS N V
SOLEShares741.97K
TypeSH
Market value$39.03M
7.20%
Sole
741.97K
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
SOLEShares713.81K
TypeSH
Market value$38.09M
7.02%
Sole
713.81K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares358.30K
TypeSH
Market value$33.89M
6.25%
Sole
358.30K
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares2.02M
TypeSH
Market value$27.71M
5.11%
Sole
2.02M
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares400.77K
TypeSH
Market value$25.32M
4.67%
Sole
400.77K
Shared
0.00
None
0.00
INSMED INC
SOLEShares249.06K
TypeSH
Market value$25.07M
4.62%
Sole
249.06K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares1.83M
TypeSH
Market value$20.71M
3.82%
Sole
1.83M
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares162.97K
TypeSH
Market value$20.48M
3.78%
Sole
162.97K
Shared
0.00
None
0.00
MERUS N V
SOLEShares382.50K
TypeSH
Market value$20.12M
3.71%
Sole
382.50K
Shared
0.00
None
0.00
89BIO INC
SOLEShares2.04M
TypeSH
Market value$20.00M
3.69%
Sole
2.04M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares1.80M
TypeSH
Market value$18.28M
3.37%
Sole
1.80M
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares235.58K
TypeSH
Market value$17.97M
3.31%
Sole
235.58K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares204.59K
TypeSH
Market value$17.14M
3.16%
Sole
204.59K
Shared
0.00
None
0.00
SPDR SERIES TRUST
SOLEShares200K
TypeSH
Market value$16.59M
3.06%
Sole
200K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares86.55K
TypeSH
Market value$14.94M
2.75%
Sole
86.55K
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares541.03K
TypeSH
Market value$14.07M
2.59%
Sole
541.03K
Shared
0.00
None
0.00
VERACYTE INC
SOLEShares448.50K
TypeSH
Market value$12.12M
2.24%
Sole
448.50K
Shared
0.00
None
0.00
SCHOLAR ROCK HLDG CORP
SOLEShares341.01K
TypeSH
Market value$12.08M
2.23%
Sole
341.01K
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares410K
TypeSH
Market value$11.64M
2.15%
Sole
410K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares287.80K
TypeSH
Market value$9.36M
1.73%
Sole
287.80K
Shared
0.00
None
0.00
PFIZER INC
SOLEShares344.34K
TypeSH
Market value$8.35M
1.54%
Sole
344.34K
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares100.20K
TypeSH
Market value$7.65M
1.41%
Sole
100.20K
Shared
0.00
None
0.00
HELIX ACQUISITION CORP II
SOLEShares613.39K
TypeSH
Market value$6.51M
1.20%
Sole
613.39K
Shared
0.00
None
0.00
GOSSAMER BIO INC
SOLEShares5.15M
TypeSH
Market value$6.33M
1.17%
Sole
5.15M
Shared
0.00
None
0.00
METSERA INC
SOLEShares207.58K
TypeSH
Market value$5.91M
1.09%
Sole
207.58K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MERUS N VSOLE | COM | 741.97K | SH | $39.03M 7.20% | 741.97K | 0.00 | 0.00 |
AKERO THERAPEUTICS INCSOLE | COM | 713.81K | SH | $38.09M 7.02% | 713.81K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 358.30K | SH | $33.89M 6.25% | 358.30K | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 2.02M | SH | $27.71M 5.11% | 2.02M | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 400.77K | SH | $25.32M 4.67% | 400.77K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 249.06K | SH | $25.07M 4.62% | 249.06K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 1.83M | SH | $20.71M 3.82% | 1.83M | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 162.97K | SH | $20.48M 3.78% | 162.97K | 0.00 | 0.00 |
MERUS N VSOLE | CALL | 382.50K | SH | $20.12M 3.71% | 382.50K | 0.00 | 0.00 |
89BIO INCSOLE | COM | 2.04M | SH | $20.00M 3.69% | 2.04M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 1.80M | SH | $18.28M 3.37% | 1.80M | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 235.58K | SH | $17.97M 3.31% | 235.58K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 204.59K | SH | $17.14M 3.16% | 204.59K | 0.00 | 0.00 |
SPDR SERIES TRUSTSOLE | CALL | 200K | SH | $16.59M 3.06% | 200K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 86.55K | SH | $14.94M 2.75% | 86.55K | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 541.03K | SH | $14.07M 2.59% | 541.03K | 0.00 | 0.00 |
VERACYTE INCSOLE | COM | 448.50K | SH | $12.12M 2.24% | 448.50K | 0.00 | 0.00 |
SCHOLAR ROCK HLDG CORPSOLE | COM | 341.01K | SH | $12.08M 2.23% | 341.01K | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | COM | 410K | SH | $11.64M 2.15% | 410K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 287.80K | SH | $9.36M 1.73% | 287.80K | 0.00 | 0.00 |
PFIZER INCSOLE | COM | 344.34K | SH | $8.35M 1.54% | 344.34K | 0.00 | 0.00 |
NUVALENT INCSOLE | CALL | 100.20K | SH | $7.65M 1.41% | 100.20K | 0.00 | 0.00 |
HELIX ACQUISITION CORP IISOLE | CL A ORD SHS | 613.39K | SH | $6.51M 1.20% | 613.39K | 0.00 | 0.00 |
GOSSAMER BIO INCSOLE | COM | 5.15M | SH | $6.33M 1.17% | 5.15M | 0.00 | 0.00 |
METSERA INCSOLE | COM | 207.58K | SH | $5.91M 1.09% | 207.58K | 0.00 | 0.00 |
Page 1 of 3